| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8784937 | Advances in Radiation Oncology | 2017 | 27 Pages |
Abstract
Compared with ssIMRT, VMAT had better target conformity with similar organ sparing and comparable rates of survival, recurrence, and toxicity. These results suggest that VMAT can be safe and effective for esophageal cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Cai MD, Mian MD, Ritsuko MD, Peter A. PhD, Meilin PhD, Brian P. PhD, Luhua MD, Steven H. MD, PhD,